Content about Pharmaceutical industry in China

May 17, 2012
Sagent launches generic chemotherapy drug

Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.

May 16, 2012
CVS Caremark study: Focus on Rx adherence saved PBM clients $2.4B in 2011

CVS Caremark has aggressively set its sights on enhancing medication adherence, and the initiatives are paying off as the company estimates that its PBM clients saved nearly $2.4 billion in 2011 because of improved medication adherence for chronic conditions, according to findings of its annual Insights Report.

May 10, 2012
New office to help integrate Actavis into Watson

Generic drug maker Watson Pharmaceuticals has formed a special office to handle its pending acquisition of Actavis, the company said.

April 18, 2012
Valeant buys product lines from Atlantis Pharma for $71 million

Valeant Pharmaceuticals International is acquiring "certain assets" of a drug maker based in Mexico.

April 4, 2012
Patents covering Sanctura XR invalid, court rules

A court has ruled that patents covering a drug used for overactive bladder are invalid, a company looking to launch a generic version of the drug said.

March 28, 2012
Medication mix-ups: A deadly toll

It’s common knowledge that pharmaceuticals have provided humankind with almost miraculous benefits over the past century in their ability to prevent, cure or reduce the impact of disease and to prolong life. But serious errors in the way medicines are dispensed by pharmacies and self-administered by patients are taking a big and growing toll on patients’ well-being.

March 26, 2012
Suppliers, FDA shine spotlight on switches

The recent Food and Drug Administration public meeting on driving future switch potential by way of the pharmacist and/or health technology sparked some discussion on what’s next.


March 19, 2012
Watson challenges Abbott patent on Niaspan

Watson Pharmaceuticals is challenging the patent protection on a drug made by Abbott for treating cholesterol, the company said.

March 14, 2012
Endo seeks tougher standards for generic versions of Lidoderm

Endo Pharmaceuticals is hoping the Food and Drug Administration will back tougher regulatory approval requirements for generic versions of one of its drugs.

February 27, 2012
FDA declines to approve Watson reproductive drug

The Food and Drug Administration turned down an application for a topical reproductive drug made by Watson Pharmaceuticals and Columbia Labs, the two companies said Monday.

February 22, 2012
Novartis to pay $440 million for hepatitis C drug

Novartis plans to pay up to $440 million for rights to a drug for treating hepatitis C made by Enanta Pharmaceuticals, Enanta said.

February 13, 2012
Columbia Labs transfers NDA for reproductive drug to Watson

Columbia Labs has transferred a new drug application for a topical drug designed to prevent premature birth in pregnant women to Watson Pharmaceuticals.

February 1, 2012
Impax licenses migraine drug rights from AstraZeneca

Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.

January 27, 2012
Watson, Mallinckrodt settle over generic painkiller

Watson Pharmaceuticals and Mallinckrodt have reached a settlement concerning a painkiller for which the former had sought Food and Drug Administration approval.

January 26, 2012
Federal court clears way for Watson, Amphastar to launch generic version of Lovenox

A federal court has stopped an injunction that would have prevented drug maker Watson Pharmaceuticals and partner company Amphastar Pharmaceuticals from marketing or selling a generic version of a blood-thinning drug.

January 24, 2012
Watson acquires Ascent Pharmahealth

Watson Pharmaceuticals has acquired the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab for $392.4 million in cash.

January 19, 2012
Watson launches generic version of Bayer's Yaz

Generic drug maker Watson Pharmaceuticals has launched its version of a contraceptive made by Bayer HealthCare Pharmaceuticals, Watson said.

January 18, 2012
Jazz Pharmaceuticals, Azur Pharma combine

Jazz Pharmaceuticals and Azur Pharma will become one company, the two drug makers said.

January 9, 2012
Mylan seeks approval for generic diabetes drug

Generic drug maker Mylan is challenging the patent on a drug used to treat diabetes, the company said Monday.

January 6, 2012
Achillion receives fast-track designation for hepatitis C drug

The Food and Drug Administration has granted fast-track designation to a drug currently under development by Achillion Pharmaceuticals for hepatitis C, the company said.

December 13, 2011
Amneal makes new executive appointments

Generic drug maker Amneal Pharmaceuticals has added four new executives, the company said.

December 13, 2011
Report: Authorized generic versions of Lipitor capture 14.6% of script volume

Though they've been on the market for less than a month, the generic and authorized generic versions of Pfizer's cholesterol-lowering drug Lipitor have captured more than one-tenth of prescriptions, according to published reports.

December 9, 2011
FDA approves Antares Pharma's overactive bladder drug

The Food and Drug Administration has approved a topical gel made by Antares Pharma for overactive bladder.

December 8, 2011
GPhA appoints new executive

The Generic Pharmaceutical Association has appointed a new executive who will help guide the organization's newly created research and education institute.

November 28, 2011
Bayer, Regeneron start phase-3 trial of Eylea for wet AMD in China

Bayer HealthCare and Regeneron Pharmaceuticals have started a late-stage clinical trial in China to evaluate a drug for eye disorders, the companies said Monday.

© 2012 Drug Store News. All Rights Reserved.